FDA Approved Products

4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: LOE ApproachingClear all
ORTHO CYCLEN-21
ethinyl estradiol; norgestimate
LOE Approaching
Johnson & Johnson
ORAL-21 · TABLET
1989
NDA
30/100
ORTHO CYCLEN-28
ethinyl estradiol; norgestimate
LOE Approaching
Johnson & Johnson
ORAL-28 · TABLET
1989
NDA
30/100
ORTHO EVRA
ethinyl estradiol; norelgestromin
LOE Approaching
Johnson & Johnson
TRANSDERMAL · FILM, EXTENDED RELEASE
2001
NDA
30/100
ORTHO TRI-CYCLEN
ethinyl estradiol; norgestimate
LOE Approaching
Johnson & Johnson
ORAL-28 · TABLET
1992
NDA
30/100
ORTHO TRI-CYCLEN 21
ethinyl estradiol; norgestimate
LOE Approaching
Johnson & Johnson
ORAL-21 · TABLET
2005
NDA
30/100
ORTHO TRI-CYCLEN 28
ethinyl estradiol; norgestimate
LOE Approaching
Johnson & Johnson
ORAL-28 · TABLET
2005
NDA
30/100
ORTHO TRI-CYCLEN LO
ethinyl estradiol; norgestimate
LOE Approaching
Johnson & Johnson
ORAL-28 · TABLET
2002
NDA
30/100
ORTHO-CEPT
desogestrel; ethinyl estradiol
LOE Approaching
Johnson & Johnson
ORAL-28 · TABLET
1992
NDA
30/100
ORTHO-NOVUM 1/35-21
ethinyl estradiol; norethindrone
LOE Approaching
Johnson & Johnson
ORAL-21 · TABLET
1974
NDA
30/100
ORTHO-NOVUM 1/35-28
ethinyl estradiol; norethindrone
LOE Approaching
Johnson & Johnson
ORAL-28 · TABLET
1977
NDA
30/100
ORTHO-NOVUM 1/50 21
mestranol; norethindrone
LOE Approaching
Johnson & Johnson
ORAL-21 · TABLET
1962
NDA
30/100
ORTHO-NOVUM 1/50 28
mestranol; norethindrone
LOE Approaching
Johnson & Johnson
ORAL-28 · TABLET
1968
NDA
30/100
ORTHO-NOVUM 10-21
mestranol; norethindrone
LOE Approaching
Johnson & Johnson
ORAL-21 · TABLET
1962
NDA
30/100
ORTHO-NOVUM 10/11-21
ethinyl estradiol; norethindrone
LOE Approaching
Johnson & Johnson
ORAL-21 · TABLET
1982
NDA
30/100
ORTHO-NOVUM 10/11-28
ethinyl estradiol; norethindrone
LOE Approaching
Johnson & Johnson
ORAL-28 · TABLET
1982
NDA
30/100
ORTHO-NOVUM 2-21
mestranol; norethindrone
LOE Approaching
Johnson & Johnson
ORAL-21 · TABLET
1962
NDA
30/100
ORTHO-NOVUM 7/14-21
ethinyl estradiol; norethindrone
LOE Approaching
Johnson & Johnson
ORAL-21 · TABLET
1984
NDA
30/100
ORTHO-NOVUM 7/14-28
ethinyl estradiol; norethindrone
LOE Approaching
Johnson & Johnson
ORAL-28 · TABLET
1984
NDA
30/100
ORTHO-NOVUM 7/7/7-21
ethinyl estradiol; norethindrone
LOE Approaching
Johnson & Johnson
ORAL-21 · TABLET
1984
NDA
30/100
ORTHO-NOVUM 7/7/7-28
ethinyl estradiol; norethindrone
LOE Approaching
Johnson & Johnson
ORAL-28 · TABLET
1984
NDA
30/100
ORUDIS
ketoprofen
LOE Approaching
Thayer Medical
ORAL · CAPSULE
1986
SMNDA
30/100
ORUDIS KT
ketoprofen
LOE Approaching
Pfizer
ORAL · TABLET
1995
SMNDA
30/100
ORUVAIL
ketoprofen
LOE Approaching
Pfizer
ORAL · CAPSULE, EXTENDED RELEASE
1993
SMNDA
30/100
OSMITROL 10% IN WATER
mannitol
LOE Approaching
Baxter
INJECTION · INJECTABLE
1964
NDA
30/100
← PreviousPage 115 of 188Next →